01560nam 2200361z- 450 991068986820332120050503161022.0(CKB)5860000000031857(BIP)012315030(EXLCZ)99586000000003185720220406c2004uuuu -u- -engPublication and disclosure issues in antidepressant pediatric clinical trials hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, September 9, 20041 online resource (iii, 716 p.) ill0-16-074184-X Publication and Disclosure Issues in Antidepressant Pediatric Clinical TrialsAntidepressantsUnited StatesEvaluationDepression in childrenChemotherapyUnited StatesEvaluationClinical trialsUnited StatesAntidepressantsDepression in childrenClinical trialsMedical careMedicalPsychologyAntidepressantsEvaluation.Depression in childrenChemotherapyEvaluation.Clinical trialsUnited States, Congress House Committee on Energy and Commerce Subcommittee on Oversight and Investigations Staff,othBOOK9910689868203321Publication and disclosure issues in antidepressant pediatric clinical trials3171204UNINA